3-Hydroxy-O-methyl-L-tyrosine is used in the preparation of tyrosine-based components of natural products such as saframycin MX1 and its analogs, which are naturally potent anti-tumor agents currently under clinical development.
ChEBI: 4-O-methyl-L-dopa is an L-dopa in which the hydroxy group at position 4 is replaced by a methoxy group. It has a role as a human metabolite and a rat metabolite. It is a L-tyrosine derivative, a non-proteinogenic L-alpha-amino acid and a monomethoxybenzene. It is functionally related to a L-dopa. It is a tautomer of a 4-O-methyl-L-dopa zwitterion.
